Novo Nordisk today was ranked number 4 on the Science 2012 Top Employer list – up from ninth place last year. The company’s ‘innovation leadership’, ‘important quality research’ and ‘respect for employees’ and ability to inspire ‘loyalty among employees’ were cited as key drivers of this impressive global ranking.
"We’re proud to have jumped up to the top five in this widely-recognized ranking of the world’s best science employers. Our excellent researchers around the world are the main source of this company’s strong innovation. The fact that they feel respected and take pride in working for a company that operates in a sustainable way is great to see. In the battle to recruit the best researchers, there’s nothing more powerful than peer-to-peer communication," says Mads Krogsgaard Thomsen, chief science officer and executive vice president at Novo Nordisk.
R&D professionals at Novo Nordisk comprise world-class experts in the engineering, expression, formulation and delivery of therapeutic proteins, as well as in the development of compounds into safe, effective and convenient treatment options for people living with chronic conditions like diabetes, haemophilia and rheumatoid arthritis. More than 4,000 employees work in Novo Nordisk R&D in Denmark, US, China and India.
"This positive evaluation of Novo Nordisk resonates well with my own personal experience as a diabetes researcher in the company for the past 21 years. Our collaborative work in multidisciplinary teams both within and outside of the company, and our openness to explore new ideas inspire me. It gives me the confidence that I’m part of a highly-qualified team working every day to find better treatment solutions for people with diabetes," says Erica Nishimura, scientific director of Diabetes Biology at Novo Nordisk.
In the Science 2012 survey, 4,276 employees working in the biotechnology, biopharmaceutical, pharmaceutical and related industries were asked to rank the 20 best employers based on 23 characteristics, including research-driven environment and financial strength.
Source: Novo Nordisk
About the Survey: The survey has been conducted by Science Careers.
Survey Methodology (Source – Science Careers)
Science Careers conducted its annual web-based survey of individuals familiar with pharmaceutical and biotech employers to determine the best employers in the field. This survey was conducted from March 7 to March 21, 2012. Roughly 23,000 individuals from the AAAS database, as well as former survey participants, were invited via e-mail messages to take this survey. Individuals working in human resources at biotech and pharma companies (Science Careers sales database) were also contacted by e-mail and asked to promote the survey within their organization. Lastly, banner ads and e-mail blasts were run with two outside providers.
In all, 4,276 surveys were submitted, which served as the basis for the analysis. The top 20 companies were selected using a statistical process that calculates a unique ranking score for each company rated. Only companies that were rated by 30 or more respondents were eligible to become part of the top 20 best employers.